JEMAZI 500 (5 PACK) (DPCO) "AZITHROMYCIN 500mg. IP

Jemazi 500 supplies Azithromycin 500mg tablets for the treatment of mild to moderate bacterial infections. Main uses: mild to moderate community-acquired pneumonia in adults and in patients 6 months of age and older, caused by susceptible bacteria; pharyngitis and tonsillitis in adults and in patients 2 years of age and older, caused by susceptible bacteria; acute otitis media in patients 6 months of age and older, caused by susceptible bacteria; acute bacterial sinusitis in adults; acute bacterial exacerbations of chronic bronchitis in adults.

Common side effects of Jemazi 500 Tablet include diarrhoea; nausea; abdominal pain; vomiting; headache; altered taste. Get medical help at once if you notice severe liver injury, including cholestatic jaundice and hepatitis; serious allergic and skin reactions, including angioedema; prolongation of the QT interval, torsades de pointes and a potential increased short-term risk of acute cardiovascular death in adults.

Each Jemazi 500 tablet contains Azithromycin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Jemazi 500 Tablet only as your doctor advises.

The MRP of Jemazi 500 Tablet is ₹126.73 for a pack of 5x6x5 (Blister). For chemists and distributors, the PTR is ₹96.56 and the PTS is ₹86.9.

Each Jemazi 500 tablet contains Azithromycin 500 mg. It comes in a pack of 5x6x5 (Blister).

Susceptible bacteria depend on protein-making to stay alive and multiply. Azithromycin, the macrolide antibacterial in this tablet, gets in the way of that process, so the bacteria weaken and the infection is handled by the body's own defences.

Must not be used in patients with known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide drug. Must not be used in patients with a history of cholestatic jaundice or liver dysfunction linked to earlier use of azithromycin. Check with a doctor first if there is a known QT prolongation, a history of torsades de pointes or any other heart rhythm problem, or if the patient is taking other medicines that prolong the QT interval. Check with a doctor first if the patient has liver disease or myasthenia gravis. Check with a doctor first about the potential increased short-term risk of acute cardiovascular death in adults; this risk should be balanced against the treatment benefit.

Jemazi 500 Tablet is a brand of Vibcare Pharma, sold through its Auspin division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.